STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

LYTTON-KAMBARA FOUNDATION: Form 990PF, tax year 2022

View the entire original 990 at ProPublica ↗

Organization
LYTTON-KAMBARA FOUNDATION (EIN 81-4172003)
Tax period
2022-01-01 to 2022-12-31
Filed
2023-11-15
IRS object ID
202343199349110004
Schema version
2022v5.0
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2023-11-15T19:27:09-06:00ReturnTs
Tax Period End2022-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1Foundation SourceBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line13333 New Hyde Park Rd Ste 406AddressLine1Txt
CityNew Hyde ParkCityNm
State AbbreviationNYStateAbbreviationCd
ZIP11042ZIPCd
FieldValueIRS element (for citing)
Return Type990PFReturnTypeCd
Tax Period Begin2022-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN814172003EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1Lytton-Kambara FoundationBusinessNameLine1Txt
FieldValueIRS element (for citing)
In Care Of% Foundation SourceInCareOfNm
Business Name ControlLYTTBusinessNameControlTxt
Phone8008391754PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1Foundation Source 501 Silverside RdAddressLine1Txt
CityWilmingtonCityNm
State AbbreviationDEStateAbbreviationCd
ZIP198091377ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonLaurence LyttonPersonNm
Person TitlePRESIDENTPersonTitleTxt
Phone8008391754PhoneNum
Signature2023-11-14SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

FieldValueIRS element (for citing)
Person FirstLaurencePersonFirstNm
Person LastLyttonPersonLastNm
FieldValueIRS element (for citing)
SSN999009999SSN

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonJeffrey D HaskellPreparerPersonNm
PTINP01345770PTIN
Phone8008391754PhoneNum

Additional Filer Information AdditionalFilerInformation

FieldValueIRS element (for citing)
Trusted CustomerTrustedCustomerGrp
FieldValueIRS element (for citing)
Tax2022TaxYr
Build TS2023-04-26 12:10:37ZBuildTS

Form 990-PF IRS990PF

FieldValueIRS element (for citing)
Organization501c3 Exempt PFYes (X)Organization501c3ExemptPFInd
FMV Assets EOY$31,601,872FMVAssetsEOYAmt
Method Of Accounting CashYes (X)MethodOfAccountingCashInd

Analysis Of Revenue And Expenses AnalysisOfRevenueAndExpenses

FieldValueIRS element (for citing)
Contri Rcvd Rev And Expnss$545,844ContriRcvdRevAndExpnssAmt
Interest On Sav Rev And Expnss$152,570InterestOnSavRevAndExpnssAmt
Interest On Sav Net Invst Incm$152,570InterestOnSavNetInvstIncmAmt
Dividends Rev And Expnss$115,625DividendsRevAndExpnssAmt
Dividends Net Invst Incm$115,625DividendsNetInvstIncmAmt
Net Gain Sale Ast Rev And Expnss$1,110,124NetGainSaleAstRevAndExpnssAmt
Gross Sales Price$24,415,558GrossSalesPriceAmt
Cap Gain Net Incm Net Invst Incm$1,608,351CapGainNetIncmNetInvstIncmAmt
Other Income Rev And Expnss$182,223OtherIncomeRevAndExpnssAmt
Other Income Net Invst Incm$182,223OtherIncomeNetInvstIncmAmt
Total Rev And Expnss$2,106,386TotalRevAndExpnssAmt
Total Net Invst Incm$2,058,769TotalNetInvstIncmAmt
Comp Ofcr Dir Trst Rev And Expnss$0CompOfcrDirTrstRevAndExpnssAmt
Other Prof Fees Rev And Expnss$530OtherProfFeesRevAndExpnssAmt
Other Prof Fees Net Invst Incm$530OtherProfFeesNetInvstIncmAmt
Interest Rev And Expnss$85InterestRevAndExpnssAmt
Interest Net Invst Incm$85InterestNetInvstIncmAmt
Taxes Rev And Expnss$57,477TaxesRevAndExpnssAmt
Other Expenses Rev And Expnss$121,080OtherExpensesRevAndExpnssAmt
Other Expenses Net Invst Incm$14,830OtherExpensesNetInvstIncmAmt
Other Expenses Dsbrs Chrtbl$106,250OtherExpensesDsbrsChrtblAmt
Tot Opr Expenses Rev And Expnss$179,172TotOprExpensesRevAndExpnssAmt
Tot Opr Expenses Net Invst Incm$15,445TotOprExpensesNetInvstIncmAmt
Tot Opr Expenses Dsbrs Chrtbl$106,250TotOprExpensesDsbrsChrtblAmt
Contri Paid Rev And Expnss$1,478,900ContriPaidRevAndExpnssAmt
Contri Paid Dsbrs Chrtbl$1,478,900ContriPaidDsbrsChrtblAmt
Total Expenses Rev And Expnss$1,658,072TotalExpensesRevAndExpnssAmt
Total Expenses Net Invst Incm$15,445TotalExpensesNetInvstIncmAmt
Total Expenses Dsbrs Chrtbl$1,585,150TotalExpensesDsbrsChrtblAmt
Excess Revenue Over Expenses$448,314ExcessRevenueOverExpensesAmt
Net Investment Income$2,043,324NetInvestmentIncomeAmt

Form990 PF Balance Sheets Form990PFBalanceSheetsGrp

FieldValueIRS element (for citing)
Sav And Temp Cash Invst BOY$150,324SavAndTempCashInvstBOYAmt
Sav And Temp Cash Invst EOY$12,391,572SavAndTempCashInvstEOYAmt
Sav And Temp Cash Invst EOYFMV$12,391,572SavAndTempCashInvstEOYFMVAmt
Acct Rcvbl$1,267AcctRcvblAmt
Acct Rcvbl EOY$1,267AcctRcvblEOYAmt
Acct Rcvbl EOYFMV$1,267AcctRcvblEOYFMVAmt
Other Nts And Loans Rcvbl$4,000,417OtherNtsAndLoansRcvblAmt
Other Nts And Loans Rcvbl BOY$4,000,000OtherNtsAndLoansRcvblBOYAmt
Other Nts And Loans Rcvbl EOY$4,000,417OtherNtsAndLoansRcvblEOYAmt
Other Nts And Loans Rcvbl EOYFMV$3,000,417OtherNtsAndLoansRcvblEOYFMVAmt
Corporate Stock BOY$26,767,120CorporateStockBOYAmt
Corporate Stock EOY$18,819,415CorporateStockEOYAmt
Corporate Stock EOYFMV$12,266,789CorporateStockEOYFMVAmt
Corporate Bonds BOY$3,240,000CorporateBondsBOYAmt
Corporate Bonds EOY$979,005CorporateBondsEOYAmt
Corporate Bonds EOYFMV$1,287,927CorporateBondsEOYFMVAmt
Other Investments BOY$5,575,962OtherInvestmentsBOYAmt
Other Investments EOY$5,591,925OtherInvestmentsEOYAmt
Other Investments EOYFMV$2,653,900OtherInvestmentsEOYFMVAmt
Total Assets BOY$39,733,406TotalAssetsBOYAmt
Total Assets EOY$41,783,601TotalAssetsEOYAmt
Total Assets EOYFMV$31,601,872TotalAssetsEOYFMVAmt
Other Liabilities EOY$1,601,881OtherLiabilitiesEOYAmt
Total Liabilities BOY$0TotalLiabilitiesBOYAmt
Total Liabilities EOY$1,601,881TotalLiabilitiesEOYAmt
Org Does Not Follow FASB117Yes (X)OrgDoesNotFollowFASB117Ind
Retained Earning BOY$39,733,406RetainedEarningBOYAmt
Retained Earning EOY$40,181,720RetainedEarningEOYAmt
Tot Net Ast Or Fund Balances BOY$39,733,406TotNetAstOrFundBalancesBOYAmt
Tot Net Ast Or Fund Balances EOY$40,181,720TotNetAstOrFundBalancesEOYAmt
Total Liabilities Net Ast BOY$39,733,406TotalLiabilitiesNetAstBOYAmt
Total Liabilities Net Ast EOY$41,783,601TotalLiabilitiesNetAstEOYAmt

Chg In Net Assets Fund Balances ChgInNetAssetsFundBalancesGrp

FieldValueIRS element (for citing)
Tot Net Ast Or Fund Balances BOY$39,733,406TotNetAstOrFundBalancesBOYAmt
Excess Revenue Over Expenses$448,314ExcessRevenueOverExpensesAmt
Subtotal$40,181,720SubtotalAmt
Tot Net Ast Or Fund Balances EOY$40,181,720TotNetAstOrFundBalancesEOYAmt

Cap Gains Loss Tx Invst Incm Detail CapGainsLossTxInvstIncmDetail

Cap Gains Loss Tx Invst Incm CapGainsLossTxInvstIncmGrp (46 entries)

PropertyPropertyDescGross Sales PriceGrossSalesPriceAmtCost Or Other BasisCostOrOtherBasisAmtGain Or LossGainOrLossAmtGains Minus Excess Or LossesGainsMinusExcessOrLossesAmtHow AcquiredHowAcquiredCdAcquiredAcquiredDtSoldSoldDt
Publicly-traded Securities$24,164,457$22,215,166$1,949,291$1,949,291
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$10,993$20,400-$9,407-$9,407P2021-03-122022-04-14
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$5,492$10,585-$5,093-$5,093P2021-03-122022-04-19
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$2,707$5,667-$2,960-$2,960P2021-03-122022-04-20
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$2,797$5,667-$2,870-$2,870P2021-03-122022-04-20
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$3,807$7,933-$4,126-$4,126P2021-03-122022-04-20
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$2,700$5,667-$2,967-$2,967P2021-03-122022-04-20
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$2,755$5,667-$2,912-$2,912P2021-03-122022-04-20
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$6,504$13,600-$7,096-$7,096P2021-03-122022-04-20
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$2,465$5,667-$3,202-$3,202P2021-03-122022-04-22
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$4,038$9,067-$5,029-$5,029P2021-03-122022-04-22
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$2,360$5,667-$3,307-$3,307P2021-03-122022-04-25
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$2,784$6,800-$4,016-$4,016P2021-03-122022-04-25
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$1,831$4,533-$2,702-$2,702P2021-03-122022-04-27
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$2,287$5,667-$3,380-$3,380P2021-03-122022-04-27
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$9,830$24,582-$14,752-$14,752P2021-03-122022-04-27
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$4,611$13,600-$8,989-$8,989P2021-03-122022-04-29
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$25,035$78,280-$53,245-$53,245P2021-03-122022-05-02
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$11,036$33,989-$22,953-$22,953P2021-03-122022-05-02
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$1,676$5,667-$3,991-$3,991P2021-03-122022-05-04
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$3,449$11,334-$7,885-$7,885P2021-03-122022-05-04
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$3,300$11,651-$8,351-$8,351P2021-03-122022-05-04
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$1,675$5,667-$3,992-$3,992P2021-03-122022-05-04
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$3,390$11,300-$7,910-$7,910P2021-03-122022-05-04
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$3,210$11,334-$8,124-$8,124P2021-03-122022-05-04
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$5,360$22,667-$17,307-$17,307P2021-03-122022-06-17
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$9,158$21,534-$12,376-$12,376P2021-03-122022-11-09
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$7,967$17,601-$9,634-$9,634P2021-03-122022-11-10
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$16,648$28,583-$11,935-$11,935P2021-03-122022-12-07
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$1,670$3,128-$1,458-$1,458P2021-03-122022-12-12
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$4,485$8,273-$3,788-$3,788P2021-03-122022-12-12
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$6,658$12,467-$5,809-$5,809P2021-03-122022-12-12
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$3,887$6,403-$2,516-$2,516P2021-03-122022-12-14
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$4,800$8,228-$3,428-$3,428P2021-03-122022-12-14
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$675$1,133-$458-$458P2021-03-122022-12-14
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$3,655$6,279-$2,624-$2,624P2021-03-122022-12-14
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$1,120$2,267-$1,147-$1,147P2021-03-122022-12-16
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$3,027$5,667-$2,640-$2,640P2021-03-122022-12-16
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$4,295$7,934-$3,639-$3,639P2021-03-122022-12-16
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$23,243$50,660-$27,417-$27,417P2021-03-122022-12-19
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$9,478$20,809-$11,331-$11,331P2021-03-122022-12-28
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$4,006$7,934-$3,928-$3,928P2021-03-122022-12-29
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$4,013$7,933-$3,920-$3,920P2021-03-122022-12-29
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$10,672$21,216-$10,544-$10,544P2021-03-122022-12-29
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$2,756$5,667-$2,911-$2,911P2021-03-122022-12-30
OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)$2,796$5,667-$2,871-$2,871P2021-03-122022-12-30
FieldValueIRS element (for citing)
Capital Gain Net Income$1,608,351CapitalGainNetIncomeAmt

Excise Tax Based On Invst Incm ExciseTaxBasedOnInvstIncmGrp

FieldValueIRS element (for citing)
Investment Income Excise Tax$28,402InvestmentIncomeExciseTaxAmt
Subtotal$28,402SubtotalAmt
Tax Based On Investment Income$28,402TaxBasedOnInvestmentIncomeAmt
Estimated Plus Ovpmt Incm Tx$3,300EstimatedPlusOvpmtIncmTxAmt
Exempt Frgn Org Tax Wthld At Srce$0ExemptFrgnOrgTaxWthldAtSrceAmt
Extsn Request Income Tax Paid$56,500ExtsnRequestIncomeTaxPaidAmt
Total Payments And Credits$59,800TotalPaymentsAndCreditsAmt
Form2220 AttachedYes (X)Form2220AttachedInd
Es Penalty$668EsPenaltyAmt
Overpayment$30,730OverpaymentAmt
Applied To ES Tax$30,730AppliedToESTaxAmt

Statements Regarding Acty StatementsRegardingActyGrp

FieldValueIRS element (for citing)
Legislative Political ActyfalseLegislativePoliticalActyInd
More Than100 SpentfalseMoreThan100SpentInd
Form1120 POL FiledfalseForm1120POLFiledInd
Activities Not Previously RptfalseActivitiesNotPreviouslyRptInd
Changes To Articles Or BylawsfalseChangesToArticlesOrBylawsInd
Unrelated Bus Incm Over LimitfalseUnrelatedBusIncmOverLimitInd
Organization Dissolved EtcfalseOrganizationDissolvedEtcInd
Section508e Rqr SatisfiedYes (true)Section508eRqrSatisfiedInd
At Least5000 In AssetsYes (true)AtLeast5000InAssetsInd
Org Report Or Register StateDEOrgReportOrRegisterStateCd
Form990 PF Filed With Atty GenYes (true)Form990PFFiledWithAttyGenInd
Private Operating FoundationfalsePrivateOperatingFoundationInd
New Substantial ContributorsfalseNewSubstantialContributorsInd
Own Controlled EntityfalseOwnControlledEntityInd
Donor Advised FundfalseDonorAdvisedFundInd
Comply With Public Insp RqrYes (true)ComplyWithPublicInspRqrInd

Persons With Books Name PersonsWithBooksName

FieldValueIRS element (for citing)
Business Name Line1Foundation SourceBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone8008391754PhoneNum

Location Of Books US Address LocationOfBooksUSAddress

FieldValueIRS element (for citing)
Address Line1501 Silverside Road Suite 123AddressLine1Txt
CityWilmingtonCityNm
State AbbreviationDEStateAbbreviationCd
ZIP198091377ZIPCd
FieldValueIRS element (for citing)
Foreign Accounts QuestionfalseForeignAccountsQuestionInd

Statements Regarding Acty4720 StatementsRegardingActy4720Grp

FieldValueIRS element (for citing)
Sale Or Exch Disqualified PrsnfalseSaleOrExchDisqualifiedPrsnInd
Brrw Or Lend Disqualified PrsnfalseBrrwOrLendDisqualifiedPrsnInd
Furn Goods Disqualified PrsnfalseFurnGoodsDisqualifiedPrsnInd
Pay Comp Disqualified PrsnfalsePayCompDisqualifiedPrsnInd
Transfer Ast Disqualified PrsnfalseTransferAstDisqualifiedPrsnInd
Payment To Government OfficialfalsePaymentToGovernmentOfficialInd
Uncorrected Prior ActsfalseUncorrectedPriorActsInd
Undistributed Income PYfalseUndistributedIncomePYInd
Business HoldingsfalseBusinessHoldingsInd
Jeopardy InvestmentsfalseJeopardyInvestmentsInd
Uncorrected PY Jeopardy InvstfalseUncorrectedPYJeopardyInvstInd
Influence LegislationfalseInfluenceLegislationInd
Influence ElectionfalseInfluenceElectionInd
Grants To IndividualsfalseGrantsToIndividualsInd
Grants To OrganizationsfalseGrantsToOrganizationsInd
Noncharitable PurposefalseNoncharitablePurposeInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Subj To Tax Rmnrtn Ex Prcht PymtfalseSubjToTaxRmnrtnExPrchtPymtInd

Officer Dir Trst Key Empl Info OfficerDirTrstKeyEmplInfoGrp

Officer Dir Trst Key Empl OfficerDirTrstKeyEmplGrp (3 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdTitleTitleTxtAverage Hrs Per Wk Devoted To PosAverageHrsPerWkDevotedToPosRtCompensationCompensationAmtEmployee Benefit ProgramEmployeeBenefitProgramAmtExpense Account Other AllwncExpenseAccountOtherAllwncAmt
Janice Kambara
Foundation Source 501 Silverside RdWilmingtonDE198091377Dir1.0$0$0$0
Katherine Lytton
Foundation Source 501 Silverside RdWilmingtonDE198091377Dir1.0$0$0$0
Laurence Lytton
Foundation Source 501 Silverside RdWilmingtonDE198091377Dir, Pres, Sec, Treas8.0$0$0$0

Compensation Of Hghst Pd Cntrct CompensationOfHghstPdCntrctGrp

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1Foundation SourceBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line155 Walls Drive 3rd FlAddressLine1Txt
CityFairfieldCityNm
State AbbreviationCTStateAbbreviationCd
ZIP06824ZIPCd
FieldValueIRS element (for citing)
Service TypeAdministrativeServiceTypeTxt
Compensation$106,225CompensationAmt
FieldValueIRS element (for citing)
Summary Of Direct Chrtbl ActySummaryOfDirectChrtblActyGrp
Sum Of Program Related InvstSumOfProgramRelatedInvstGrp

Minimum Investment Return MinimumInvestmentReturnGrp

FieldValueIRS element (for citing)
Average Monthly FMV Of Sec$18,145,505AverageMonthlyFMVOfSecAmt
Average Monthly Cash Balances$9,160,895AverageMonthlyCashBalancesAmt
FMV All Other Noncharitable Ast$5,797,530FMVAllOtherNoncharitableAstAmt
Total FMV Of Unused Assets$33,103,930TotalFMVOfUnusedAssetsAmt
Acquisition Indebtedness$0AcquisitionIndebtednessAmt
Adjusted Total FMV Of Unused Ast$33,103,930AdjustedTotalFMVOfUnusedAstAmt
Cash Deemed Charitable$496,559CashDeemedCharitableAmt
Net Vl Noncharitable Assets$32,607,371NetVlNoncharitableAssetsAmt
Minimum Investment Return$1,630,369MinimumInvestmentReturnAmt

Distributable Amount DistributableAmountGrp

FieldValueIRS element (for citing)
Minimum Investment Return$1,630,369MinimumInvestmentReturnAmt
Tax Based On Investment Income$28,402TaxBasedOnInvestmentIncomeAmt
Total Tax$28,402TotalTaxAmt
Distributable Before Adj$1,601,967DistributableBeforeAdjAmt
Distributable Before Ded$1,601,967DistributableBeforeDedAmt
Distributable As Adjusted$1,601,967DistributableAsAdjustedAmt

PF Qualifying Distributions PFQualifyingDistributionsGrp

FieldValueIRS element (for citing)
Expenses And Contributions$1,585,150ExpensesAndContributionsAmt
Program Related Invst Total$0ProgramRelatedInvstTotalAmt
Charitable Assets Acquis Paid$0CharitableAssetsAcquisPaidAmt
Set Aside Suitability Test$0SetAsideSuitabilityTestAmt
Set Aside Cash Distri Test$0SetAsideCashDistriTestAmt
Qualifying Distributions$1,585,150QualifyingDistributionsAmt

Undistributed Income UndistributedIncomeGrp

FieldValueIRS element (for citing)
Distributable As Adjusted$1,601,967DistributableAsAdjustedAmt
Undistributed Income PY$1,565,305UndistributedIncomePYAmt
Prior Year12020PriorYear1Yr
Prior Year22019PriorYear2Yr
Prior Year32018PriorYear3Yr
Qualifying Distributions$1,585,150QualifyingDistributionsAmt
Applied To Year1$1,565,305AppliedToYear1Amt
Applied To Current Year$19,845AppliedToCurrentYearAmt
Remaining Distri From Corpus$0RemainingDistriFromCorpusAmt
Total Corpus$0TotalCorpusAmt
Undistributed Income CY$1,582,122UndistributedIncomeCYAmt
Excess Distri Cyov To Next Yr$0ExcessDistriCyovToNextYrAmt
Excess From Current Year$0ExcessFromCurrentYearAmt
FieldValueIRS element (for citing)
Private Operating FoundationsPrivateOperatingFoundationsGrp

Supplementary Information SupplementaryInformationGrp

FieldValueIRS element (for citing)
Contributing ManagerJanice KambaraContributingManagerNm
Contributing ManagerLaurence LyttonContributingManagerNm
Only Contri To PreselectedYes (X)OnlyContriToPreselectedInd

Grant Or Contribution Pd Dur Yr GrantOrContributionPdDurYrGrp (19 entries)

Address Line1RecipientUSAddress/AddressLine1TxtCityRecipientUSAddress/CityNmState AbbreviationRecipientUSAddress/StateAbbreviationCdZIPRecipientUSAddress/ZIPCdRecipient RelationshipRecipientRelationshipTxtRecipient Foundation StatusRecipientFoundationStatusTxtGrant Or Contribution PurposeGrantOrContributionPurposeTxtAmtAmt
BOWDOIN COLLEGE
4100 COLLEGE STABRUNSWICKME04011N/APCClare McWilliams Lyne Scholarship Fund$25,000
BRYN MAWR COLLEGE
101 N MERION AVEBRYN MAWRPA19010N/APCBryn Mawr Scholarship Fund$25,000
CENTRAL PARK CONSERVANCY INC
717 FIFTH AVENEW YORKNY10022N/APCGeneral & Unrestricted$500
ETHICAL CULTURE FIELDSTON SCHOOL
33 CENTRAL PARK WNEW YORKNY10023N/APCGeneral & Unrestricted$10,000
GARDINER LIBRARY
PO BOX 223GARDINERNY12525N/AGOVGeneral & Unrestricted$200
HUDSON VALLEY RAIL TRAIL ASSOCIATION INC
TOWN HALL - 12 CHURCH STHIGHLANDNY12528N/APCGeneral & Unrestricted$200
KHAN ACADEMY INC
PO BOX 1630MOUNTAIN VIEWCA94042N/APCGeneral & Unrestricted$1,000
MOHONK PRESERVE INC
3197 RTE 44 55GARDINERNY12525N/APCGeneral & Unrestricted$2,500
NATURAL RESOURCES DEFENSE COUNCIL INC
40 WEST 20TH ST 11TH FLOORNEW YORKNY10011N/APCGeneral & Unrestricted$100,000
NEW YORK PUBLIC RADIO
160 VARICK STNEW YORKNY10013N/APCGeneral & Unrestricted$500
NEW YORK-NEW JERSEY TRAIL CONFERENCE INC
600 RAMAPO VALLEY RDMAHWAHNJ07430N/APCGeneral & Unrestricted$500
NORTHWELL HEALTH FOUNDATION
2000 MARCUS AVE 2ND FLNEW HYDE PARKNY11042N/APCLenox Hill Hospital Research Laboratory of Dr. Richard L. Whelan fund$1,500
OPEN SPACE INSTITUTE INC
1350 BROADWAY RM 201NEW YORKNY10018N/APCTO SUPPORT THE ON-GOING WORK OF OSI ON THE SHAWANGUNK RIDGE$1,000,000
PARKS & TRAILS NEW YORK INC
33 ELK STALBANYNY12207N/APCGeneral & Unrestricted$300
PRO PUBLICA INC
155 AVE OF THE AMERICAS 13TH FLNEW YORKNY10013N/APCGeneral & Unrestricted$500
RIVERKEEPER INC
20 SECOR RDOSSININGNY10562N/APCGeneral & Unrestricted$500
THE FRIENDS OF THE GLOVERSVILLE PUBLIC LIBRARY INC
58 E FULTON STGLOVERSVILLENY12078N/APCGeneral & Unrestricted$200
TRUST FOR PUBLIC LAND
666 BROADWAY 9TH FLNEW YORKNY10012N/APCGeneral & Unrestricted$310,000
WIKIMEDIA FOUNDATION INC
PO BOX 98204WASHINGTONDC20090N/APCGeneral & Unrestricted$500
FieldValueIRS element (for citing)
Total Grant Or Contri Pd Dur Yr$1,478,900TotalGrantOrContriPdDurYrAmt

Analysis Income Producing Acty AnalysisIncomeProducingActyGrp

FieldValueIRS element (for citing)
Fees Contracts From Govt AgFeesContractsFromGovtAgGrp
Membership Dues And AssmntMembershipDuesAndAssmntGrp

Int On Sav And Temp Cash Invst IntOnSavAndTempCashInvstGrp

FieldValueIRS element (for citing)
Exclusion14ExclusionCd
Exclusion$152,570ExclusionAmt

Dividends And Interest From Sec Dtl DividendsAndInterestFromSecDtl

FieldValueIRS element (for citing)
Exclusion14ExclusionCd
Exclusion$115,625ExclusionAmt
FieldValueIRS element (for citing)
Net Rntl Incm Re Debt Fincd PropNetRntlIncmReDebtFincdPropGrp
Net Rntl Incm Re Not Debt Fincd PropNetRntlIncmReNotDebtFincdProp
Net Rental Income Personal PropNetRentalIncomePersonalPropGrp
Other Investment IncomeOtherInvestmentIncomeGrp

Gain Sales Ast Oth Than Invntry GainSalesAstOthThanInvntryGrp

FieldValueIRS element (for citing)
Exclusion18ExclusionCd
Exclusion$1,110,124ExclusionAmt
FieldValueIRS element (for citing)
Net Income Loss From Special EvtNetIncomeLossFromSpecialEvtGrp
Gross Profit Loss Sls Of InvntryGrossProfitLossSlsOfInvntryGrp

Other Revenue Described OtherRevenueDescribedGrp

FieldValueIRS element (for citing)
DescINTEREST INCOME FROM NOTESDesc
Exclusion14ExclusionCd
Exclusion$182,223ExclusionAmt

Subtotals Incm Producing Acty SubtotalsIncmProducingActyGrp

FieldValueIRS element (for citing)
Exclusion$1,560,542ExclusionAmt
FieldValueIRS element (for citing)
Total Income Producing Acty$1,560,542TotalIncomeProducingActyAmt

Trnsfr Trans Rln Nonchrtbl EO TrnsfrTransRlnNonchrtblEOGrp

FieldValueIRS element (for citing)
Trnsfr Of Cash To Nonchrtbl EOfalseTrnsfrOfCashToNonchrtblEOInd
Trnsfr Other Asset Nonchrtbl EOfalseTrnsfrOtherAssetNonchrtblEOInd
Sales Or Exchanges Of AssetsfalseSalesOrExchangesOfAssetsInd
Purchase Of Assets Nonchrtbl EOfalsePurchaseOfAssetsNonchrtblEOInd
Rental Of Facilities Oth AssetsfalseRentalOfFacilitiesOthAssetsInd
Reimbursement ArrangementsfalseReimbursementArrangementsInd
Loans Or Loan GuaranteesfalseLoansOrLoanGuaranteesInd
Performance Of Services EtcfalsePerformanceOfServicesEtcInd
Sharing Of Facilities EtcfalseSharingOfFacilitiesEtcInd
Relationships Nonchrtbl EOfalseRelationshipsNonchrtblEOInd

Schedule B IRS990ScheduleB

FieldValueIRS element (for citing)
Organization501c3 Exempt PFYes (X)Organization501c3ExemptPFInd
General RuleYes (X)GeneralRuleInd

Contributor Information ContributorInformationGrp (3 entries)

ContributorContributorNumAddress Line1ContributorUSAddress/AddressLine1TxtCityContributorUSAddress/CityNmState AbbreviationContributorUSAddress/StateAbbreviationCdZIPContributorUSAddress/ZIPCdTotal ContributionsTotalContributionsAmtNoncash ContributionNoncashContributionInd
Isabel Lytton 2014 Trust
1467 CENTRAL PARK WEST 17-ANew YorkNY10025$118,051Yes (X)
Kate Lytton 2014 Trust
2467 CENTRAL PARK WEST 17-ANew YorkNY10025$140,292Yes (X)
William Lytton Trust
3467 CENTRAL PARK WEST 17-ANew YorkNY10025$287,500Yes (X)

Non Cash Property Contribution NonCashPropertyContributionGrp (3 entries)

ContributorContributorNumNoncash PropertyNoncashPropertyDescFair Market ValueFairMarketValueAmtReceivedReceivedDt
1Verttex Energy, Inc VTNR, 12208 sh.$118,0512022-03-31
2Verttex Energy, Inc VTNR, 14508 sh.$140,2922022-03-31
3Apollo Endosurgery APEN, 50000 sh.$287,5002022-09-16

Depreciation Schedule DepreciationSchedule

Investments Corp Bonds Schedule InvestmentsCorpBondsSchedule

Investments Corporate Bonds InvestmentsCorporateBondsGrp (2 entries)

BondBondNmEOY Book ValueEOYBookValueAmtEOYFMVEOYFMVAmt
PARATEK PHARMACEUTICALS INC -$349,005$347,680
VERTEX ENERGY INC BOND - 6.250$630,000$940,247

Investments Corp Stock Schedule InvestmentsCorpStockSchedule

Investments Corporate Stock InvestmentsCorporateStockGrp (41 entries)

StockStockNmEOY Book ValueEOYBookValueAmtEOYFMVEOYFMVAmt
ALBIREO PHARMA INC$1,073,548$1,093,120
ALDEYRA THERAPEUTICS INC$252,047$475,702
ALIGOS THERAPEUTICS INC$5,744$4,926
ALPINE IMMUNE SCIENCES$602,072$869,498
ATYR PHARMA INC COM NEW$979,311$269,271
BEYOND AIR$5,001$5,601
BIONOMICS$42,490$18,135
CALL - XFOR @ 2 02/17/2023$616$118
CELLECTAR BIOSCIENCES COMMON W
CELLECTAR BIOSCIENCES PRE FUND$740,661$607,452
CLEARPOINT NEURO INC$87,558$77,077
COHU INC$371,505$410,240
CONFORMIS INC$35,452$7,968
DIAMEDICA THERAPEUTICS INC$1,246,881$502,570
DUOS TECHNOLOGIES GROUP INC$1,005,000$670,000
ELECTROVAYA CMN WTS
ELECTROVAYA INC$1,199,999$1,430,496
ELEDON PHARMACEUTICALS ORD SHS$48,922$25,992
EMCORE CORPORATION$1,411,399$612,945
EXAGEN INC COM$23,895$6,288
GIGA-TRONICS INC - WARRANT$749,999$156,923
LAKELAND INDUSTRIES, INC.$45,510$32,159
LIQTECH INTERNATIONAL INC$2,101,051$151,522
MIROMATRIX MED INC$361,791$120,195
NUVVE HOLDING CORP WARRANTS
NYXOAH ORD SHS$2,977$2,445
OMNIQ CORP COMMON$210,931$131,380
ORYZON GENOMICS$32,119$22,498
PERFORMANT FINANCIAL$147,336$136,458
PLUG POWER INC$1,465$6,185
QUICKLOGIC$1,510,180$1,182,200
RENEO PHARMACEUTICALS ORD SHS$42,757$15,921
REPRO MEDSYSTEMS INC$53,175$63,885
SCIENTIFIC INDUSTRIES$400,004$400,004
SCIENTIFIC INDUSTRIES, INC - C$902,776$1,045,319
SCIENTIFIC INDUSTRIES, INC - W$92,000
SEELOS THERAPEUTICS INC$8,100$3,400
SPECTRA7 MICROSYSTEMS INC$2,006,400$568,670
UROGEN PHARMA LTD$529,723$521,804
VERRICA PHARMACEUTICALS INC$5,495$5,308
X4 PHARMACEUTICALS$575,525$521,114

Investments Other Schedule2 InvestmentsOtherSchedule2

Investments Other InvestmentsOtherGrp (4 entries)

Category Or ItemCategoryOrItemTxtBook ValueBookValueAmtEOYFMVEOYFMVAmt
LIFESCI VENTURE SPV XIII LLC$1,214,664$1,214,663
LIQTECH INTL INC - (PRE-FUNDED$2,969,301$233,700
MAXONA PHARMACEUTICALS, INC. P$1,000,000$1,000,000
OMEGA THERAPEUTICS, INC PFD SE$407,960$205,537

Other Expenses Schedule OtherExpensesSchedule

Other Expenses Schedule OtherExpensesScheduleGrp (4 entries)

DescDescRevenue And Expenses Per BooksRevenueAndExpensesPerBooksAmtDisbursements Charitable PrpsDisbursementsCharitablePrpsAmtNet Investment IncomeNetInvestmentIncomeAmt
Administrative Fees$106,225$106,225
Bank Charges$2,382$2,382
K-1 Exp LIFESCI VENTURE SPV XI$12,448$12,448
State or Local Filing Fees$25$25

Other Income Schedule2 OtherIncomeSchedule2

Other Income Detail OtherIncomeDetail

FieldValueIRS element (for citing)
DescInterest Income from NotesDesc
Revenue And Expenses Per Books$182,223RevenueAndExpensesPerBooksAmt
Net Investment Income$182,223NetInvestmentIncomeAmt

Other Liabilities Schedule OtherLiabilitiesSchedule

Other Liabilities Detail OtherLiabilitiesDetail

FieldValueIRS element (for citing)
DescSHORT SALES OF APENDesc
EOY Book Value$1,601,881EOYBookValueAmt

Other Notes Loans Rcvbl Long Sch OtherNotesLoansRcvblLongSch

Other Notes Loans Rcvbl Long OtherNotesLoansRcvblLongGrp (3 entries)

Loan OriginalLoanOriginalAmtBalance DueBalanceDueAmtNoteNoteDtLoan MaturityLoanMaturityDtRepayment TermsRepaymentTermsTxtInterestInterestRtSecurity Provided BorrowerSecurityProvidedBorrowerTxtLoan PurposeLoanPurposeTxtLender ConsiderationLenderConsiderationDesc
SPECTRA7 MICROSYSTEMS INC
$2,000,417$2,000,4172022-072024-12INT/PRIN DUE SEMI-ANNU&ON MATURITY14.NONEINVESTMENTCASH 0 CASH 0 CASH 0
CYREN LTD
$1,000,000$1,000,0002020-032024-03INT/PRIN DUE SEMI-ANNU&ON MATURITY5.75NONEINVESTMENTCASH 0 CASH 0 CASH 0
CIRCULOGENE THERANOSTICS INC
$1,000,000$1,000,0002021-032025-04INT&PRIN DUE ANNUALLY&ON MATURITY5.NONEINVESTMENTCASH 0 CASH 0 CASH 0

Other Professional Fees Schedule OtherProfessionalFeesSchedule

Other Professional Fees Detail OtherProfessionalFeesDetail

FieldValueIRS element (for citing)
CategoryInvestment Management ServicesCategoryTxt
Amt$530Amt
Net Investment Income$530NetInvestmentIncomeAmt

Taxes Schedule TaxesSchedule

Taxes Detail TaxesDetail (3 entries)

CategoryCategoryTxtAmtAmt
990-PF Estimated Tax for 2022$3,300
990-PF Excise Tax for 2021$42,477
990-PF Extension for 2021$11,700